SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucell (ICCC) - Potential Treatment for Cryptosporidium
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Steve who wrote ()7/3/1996 1:34:00 PM
From: Steve   of 46
 
I bought in to ICCC at $4.00. Since then the stock has dropped to around 3 1/2, at which point I purchased more. In one of the research efforts, ICCC is developing vaccines for Crypto. If successful, the stock could easily double in price. For comparison, other biotechs in similar phases of R&D have market caps typically around $50 M. ICCC's market cap is only $8 M.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News